已收盤 05-08 16:00:00 美东时间
-0.040
-3.08%
- This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has allowed and issued patents in the US, Australia, and Japan covering
04-02 20:38
Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(1.52) per share which beat the analyst consensus estimate of $(1.54) by 1.3 percent. This is a 83.48 percent increase over losses of $(9.20) per share
03-27 05:18
Gainers Azitra (AMEX:AZTR) stock moved upwards by 87.3% to $0.33 during Friday...
03-20 20:05
https://patentcenter.uspto.gov/applications/17546001/ifw/docs
03-20 04:00
Shares of Comfort Systems USA Inc (NYSE:FIX) rose sharply in pre-market trading...
02-20 18:16
The Company's innovative acne kit represents a new approach to acne treatment by targeting the underlying acne-causing mechanisms with enhanced precision and effectiveness. Unlike traditional therapies, the Company
01-20 21:09
Shares of Fonar Corp (NASDAQ:FONR) rose sharply in pre-market after the company...
2025-12-30 17:43
U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, CapsoVision down 11%.
2025-12-30 13:54
Dermata Therapeutics rose after announcing a private placement offering of common shares, Series C warrants, and Series D warrants.
2025-12-25 00:32
Dermata Therapeutics shares are trading higher. The company announced a $12.4 m...
2025-12-24 21:57